Ewen Callaway A tray holds supplies for administering monoclonal antibodies to treat COVID-19.Credit: Kayana Szymczak/Bloomberg/Getty A first-of-its-kind analysis has a clear message about when to give the COVID-19 therapies called monoclonal antibodies: the earlier people get this type of treatment, the better they fare1. The study, based on dozens of clinical trials, also suggests that...
